Jointown has signed a strategic cooperation agreement with National Pension Insurance Company Limited. The two sides will establish a long-term strategic partnership and carry out innovative cooperation in areas such as pension finance plus pharmaceutical services. Because Huang Tao, a non-independent director candidate the company plans to nominate, is a director and senior executive of National Pension Insurance, this transaction constitutes a connected transaction. Jointown said the agreement aims to leverage the company's strengths, including its efficient pharmaceutical supply chain capabilities, nationwide pharmaceutical distribution and retail network, and rich accumulation of pharmaceutical industry data, and combine them with National Pension Insurance's professional advantages in pension finance, to explore a new business format and model of pension finance plus pharmaceutical services that is convenient, beneficial to the public, and broadly inclusive. The company cautioned that the agreement signed this time is a framework document, and specific cooperation projects will be negotiated and signed separately as business contracts. It is not expected to have a material impact on the company's 2026 operating results for the time being, and there is uncertainty in subsequent cooperation. In addition, Jointown issued its second tranche of super short-term commercial paper for 2026, supporting the elderly care industry, on April 22, 2026, with an issuance size of 300 million yuan and a coupon rate of 1.53 percent, becoming the first private enterprise in China's pharmaceutical distribution industry to issue elderly care bonds.
Jointown Pharmaceutical Group Co LtdPartnership with National Pension Insurance to develop pension finance plus pharmaceutical services, leveraging its distribution network and data.
Strategic cooperation with Jointown to explore pension finance plus pharmaceutical services, expanding its business scope.
